Log In
Print this Print this

Intuniv, guanfacine extended release, guanfacine hydrochloride (S-877503) (formerly Connexyn, SPD503)

Also known as: GXR

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionAdrenergic receptor alpha 2a (ADRA2A) agonist
Molecular Target Adrenergic receptor alpha 2a (ADRA2A)
Mechanism of ActionAdrenoceptor alpha 2a agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAttention deficit hyperactivity disorder (ADHD)
Indication DetailsTreat attention deficit hyperactivity disorder (ADHD); Treat attention deficit hyperactivity disorder (ADHD) in children who exhibit oppositional behavior
Regulatory Designation


Shionogi & Co. Ltd.

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today